Pharmaceutical innovation is accelerating — from gene therapies and mRNA vaccines to AI-driven drug discovery and digital health integrations. Yet, for all the cutting-edge science and R&D investment, one challenge remains stubbornly consistent: market readiness.
A breakthrough compound is only as valuable as its path to adoption. And in the highly regulated, risk-averse, and...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
